Brooks Laboratories Ltd.
BROOKS Share PricePharmaceuticals & Drugs
₹147.72
-3.3 (-2.2%)
As on September 8, 2025
Exchange Scrips: BSE533543NSEBROOKSISININE650L01011
Market Cap ₹ 424 Cr
P/E Ratio -19.79
Dividend Yield N/A
Performance
Market performance
Open152.99
High152.99
Volumes58,687
Prev147.72
Low146.01
As on2025-09-08
Historical performance
1 Year High198.86
3 Year High198.86
5 Year High198.86
1 Year Low95.55
3 Year Low56.95
5 Year Low37.99
Fundamentals
Company Valuation
Market Cap (₹Cr)
424
Face Value (₹)
10
P/E Ratio
-19.79
Dividend Yield
N/A
Investment Returns
1 Year
13.6%
3 Years
11.4%
5 Years
271%
10 Years
176.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 143.62 | Bullish |
| 10-DMA | 141.09 | Bullish |
| 20-DMA | 145.97 | Bullish |
| 50-DMA | 149.35 | Bearish |
| 100-DMA | 142.33 | Bullish |
| 200-DMA | 142.18 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 8 | 8 | 9 | 9 | 9 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 8 | 8 | 9 | 9 | 9 |
| Public Investors | 10309 | 10529 | 10512 | 11273 | 11534 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -19.79.
- 3Y Stock Price CAGR of the stock is 3.9.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹42 Million.
- The company generated revenue of ₹795 Million in the previous financial year.
Brooks Laboratories Ltd.
147.72-3.3 (-2.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1081801.5
No. of Shares: 7323 (Approx)
Performance:8.2%
P/L: ₹81801.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent